4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156177
Chief Financial Officer gave up 380 shares (to pay taxes)
- Chief Financial Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ruffo Frank · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-12-18 | Exercise or conversion : show line 1 in the form | +1,250 | 143,952 | D | ||
| 2016-12-18 | Shares withheld for taxes : show line 2 in the form | −380 | $31.25 | $11,875 | 143,572 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-12-18 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,250 | 3,750 | D |
Loading xslF345X03/doc4.xml…